株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

世界のコンパニオンアニマル医療市場

Global Companion Animal Health Market - Growth, Trends and Forecasts (2017 - 2022)

発行 Mordor Intelligence LLP 商品コード 319394
出版日 ページ情報 英文 190 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=112.63円で換算しております。
Back to Top
世界のコンパニオンアニマル医療市場 Global Companion Animal Health Market - Growth, Trends and Forecasts (2017 - 2022)
出版日: 2017年01月24日 ページ情報: 英文 190 Pages
概要

当レポートでは、世界のコンパニオンアニマル医療市場の現状と将来予測、セグメント別、地域別動向とともに、主要な参入企業の競合環境とプロファイルなどをまとめています。

第1章 イントロダクション

第2章 市場分析

  • 動物医療製品
  • 動物医療と人間医療

第3章 市場動向

  • 市場促進因子
  • 市場阻害因子
  • ポーターズファイブフォース分析

第4章 市場セグメンテーション

  • 製品別
    • 寄生虫駆除剤
    • 抗炎症薬
    • 医療用食品添加物
    • その他の医薬品
    • ワクチン
  • コンパニオンアニマル

第5章 世界のコンパニオンアニマル診断薬市場

  • 酵素結合免疫吸着検査法
  • 即時免疫移動
  • 寒天ゲル免疫核酸法

第6章 世界のコンパニオンアニマル遺伝学市場

第7章 地域別市場セグメンテーション

  • 北米
  • 欧州
  • アジア太平洋地域

第8章 競合環境

  • 市場における主要企業
  • 合併・買収
  • 新製品上市
  • 協定、連携、パートナーシップ
  • その他

第9章 企業プロファイル

第10章 付録

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次

Description

The global market for companion animal healthcare is valued at $9.16 billion in 2013. Expected to grow at a CAGR of 7.86%, the market is set to reach $13.37 billion by 2020.

The companion animal health market is segmented based on type of products i. e Vaccines, Paraciticides, Anti-infectives, Medicinal feed additives, and other pharmaceuticals, based on diagnostics i.e Enzyme Linked Immuno sorbent assay(ELISA), Rapid Immuno Migration( RIM), based on genetics,based on geography market is divided into North America, Asia-Pacific, Europe and Rest of World. Europe accounts for the largest share of the animal vaccines market, followed by North America. The developing regions like Asia-pacific and Africa are expected to form a new revenue pocket in the market. Countries such as India, China, Brazil will be the major contributors in the market.

Pfizer (U.S.), Merck (U.S.), Sanofi-Aventis (France), Bayer HealthCare (Germany), Virbac (France), Novartis (Switzerland), Boehringer Ingelheim (Germany), Heska Corporation (U.S.), Bioniche Animal Health Canada, Inc. (Canada), and Ceva (France) are the key players in the global companion animal health market

What makes our report unique?

1) In depth analysis of current market trends and future forecasts of the market based on different products available for both companion animals and farm animals

2) We provide longest possible market segmentation of the market based on products available, diagnostics, genetics , and geography. We give you the competitive landscape for the market which provides information about major players in the market, Market Share and recent developments.

3) High level analysis on products i.e Vaccines, anti-infectants, MFA, Paraciticides andintroduced novel vaccines such as DNA and recombinant vaccines.

Table of Contents

1.INTRODUCTION

  • 1.1 Market Definition
  • 1.2 Market Recent Trends

2. Market Analysis

  • 2.1 Market Animal Health Products
  • 2.2 Animal medicines vs human Medicines

3. Market Dynamics

  • 3.1 Market Drivers
    • 3.1.1 Increase in pet ownership
    • 3.1.2 Improved Nutrition
    • 3.1.3 Intensifying consumer focus on food safety
    • 3.1.4 Greater Livestock production
    • 3.1.5 Increasing Zoonotic and Foodborne Diseases
  • 3.2 Market Constraints
    • 3.2.1 Scarcity of arable land and water
    • 3.2.2 Increased competition for cultivated land
    • 3.2.3 Cost effective production
  • 3.3 Porter's Five Force Analysis
    • 3.3.1 Threat of New Entrant
    • 3.3.2 Internal Rivalry
    • 3.3.3 Buyer bargaining power
    • 3.3.4 Supplier bargaining power
    • 3.3.5 Threat of substitutes

4.Market Segmentation

  • 4.1 Global Companion Animal Market Segmentation- By products
    • 4.1.1 Paraciticides
    • 4.1.2 Anti-Infectives
    • 4.1.3 Medicinal Feed Additives
    • 4.1.4 Other Pharmaceuticals
    • 4.1.5 Vaccines
  • 4.2 .Companion Animals
    • 4.2.1 Dogs
    • 4.2.2 Cats
    • 4.2.3 Horses

5. Global Companion Animal Diagnostics Market

  • 5.1 Enzyme Linked Immuno Sorbent Assay( ELISA)

5. 2 Rapid Immuno Migration( RIM)

5. 3 Agar gel Immuno Diffusion( AGID)

6. Global Companion Animal Genetics Market

  • 6.1 HD 50K for Angus
  • 6.2 CLARIFIDE for Dairy
  • 6.3 Sheep 50K
  • 6.4 CLARIFIDE for Nelore
  • 6.5 Others

7. Global Companion Market Segmentation, By Geography

  • 7.1 North America
    • 7.1.1 US
    • 7.1.2 Mexico
    • 7.1.3 Canada
  • 7.2 Europe
    • 7.2.1 France
    • 7. 2.2 Italy
    • 7.2.3 Germany
    • 7.2.4 Spain
    • 7.2.5 UK
  • 7.3 Asia-Pacific
    • 7.3.1 India
    • 7.3.2 China
    • 7.3.3 Japan
    • 7.3.4 Rest of Asia-Pacific

8. Competitive landscape

  • 8.1 Major players in the market
  • 8.2 mergers and acquisitions
  • 8.3 New product launches
  • 8.4 Agreement, Collaborations and Partnerships
  • 8.5 Recommendations for new players in the market
  • 8.6 Recommendations for existing players in the market
  • 8.7 Market Share Analysis

9. Company Profiles

  • 9.1 Zoetis animal healthcare
    • 9.1.1 Financial Overview
    • 9.1.2 Business overview
    • 9.1.3 Business strategies
  • 9.2 Merck
    • 9.2.1 Financial Overview
    • 9.2.2Business overview
    • 9.2.3 Business strategies
  • 9.3 Merial (Animal Health Division Of Sanofi)
    • 9.3.1 Financial Overview
    • 9.3.2 Business overview
    • 9.3.3 Business strategies
  • 9.4 Elanco
    • 9.4.1 Financial Overview
    • 9.4.2 Business overview
    • 9.4.3 Business strategies
  • 9.5 Bayer healthcare
    • 9.5.1 Financial Overview
    • 9.5.2 Business overview
    • 9.5.3 Business strategies
  • 9.6 Novartis Animal Health, Inc.
    • 9.6.1 Financial Overview
    • 9.6.2 Business overview
    • 9.6.3. Business strategies
  • 9.7 Virbac
    • 9.7.1 Financial Overview
    • 9.7.2 Business overview
    • 9.7.3 Business strategies
  • 9.8 Boehringer Ingelheim
    • 9.8.1 Financial Overview
    • 9.8.2 Business overview
    • 9.8.3 Business strategies

10. Appendix

  • 10.1.Abbreviations
  • 10.2.Sources
  • 10.3.Bibliography
  • 10.4.Disclaimer
Back to Top